Mode
Text Size
Log in / Sign up
N/A N=30

In Vivo Determination of 3D Patellofemoral Mechanics

Arthroplasty Replacement Knee · Knee Prosthesis

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jan 2014
Primary outcome: Primary: Patella Flexion With Respect to Femur — 80.0; 83.4; 93.7 degrees

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Subjects implanted with DePuy LCS PS RP TKA (Device); Subjects implanted with DePuy Sigma PS RP TKA (Device)
Age
Adult, Older Adult · 20+ yrs
Sex
All
Sponsor
The University of Tennessee, Knoxville
Primary completion
Sep 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Patella Flexion With Respect to Femur
80.0; 83.4; 93.7
PRIMARY
Patella Rotation With Respect to Femur
.5; -.06; -1.6
PRIMARY
Patella Tilt With Respect to Femur
4.2; 2.6; 5.3
PRIMARY
Normalized Medial Patella Contact Point Translation
.34; .12; .40
PRIMARY
Normalized Lateral Patella Contact Point Translation
0.09; .20; .45

Summary

This study will analyze the tibio-femoral and patellofemoral (motion) and mechanics (forces) of participants having a normal knee or a total knee arthroplasty (TKA) using one or two different (TKA) devices Low Contract Stress (LCS) Posterior Stabilizing (PS) Rotating Platform (RP) Total Knee Arthroplasty (TKA). All knees will be analyzed using an image matching technique that will convert a two-dimensional (2D) fluoroscopic image into a three-dimensional (3D) image. In conjunction with the fluoroscopic analysis, electromyography (EMG) data, and ground reaction force (GRF) data will all be allow for a complete analysis of the knee joints. These results will help the orthopaedic community better understand knee motion so they can improve testing on existing implants and develop future implants that will further enhance patients' lives.

Eligibility Criteria

Inclusion Criteria

  • Patients must be at least six months post-operative.
  • Potential subjects will have a body weight of less than 250 lbs.
  • Candidates must have an AKS score >70 post-operatively.
  • Patients must have passive flexion of at least 100.
  • Implanted group must have either an LCS PS RP TKA, having an anatomical patella, or Sigma PS RP TKA; or normal knee group must have normal knee.
  • Must be willing to sign both Informed Consent and HIPAA forms.

Exclusion Criteria

  • Pregnant females.
  • Subjects not meeting study requirements.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01290627). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search